Blog
All the latest news from Check4Cancer
UK Skin cancer incidence risen 45% in 10 years
19 July 2019
Cancer Research UK has recently reported that the incidence of melanoma, the most serious type of skin cancer, has risen by 4...
Cervical screening awareness week June 2019
14 June 2019
Cervical cancer is nearly always preventable. HPV (Human papillomavirus) is a sexually transmitted virus that is extremely co...
Annual screening detects breast cancers earlier for women aged 35-39 with a family history
13 February 2019
First long-term study (FH02) from University of Manchester confirming effectiveness of annual screening mammography&nb...
Check4Cancer launches innovative prostate cancer diagnosis pathway with AXA PPP healthcare
26 November 2018
Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives. Indeed, with Menâ€...
PREDICT model wins research excellence award
23 November 2018
The PREDICT breast cancer survival and treatment prediction model won the People's Choice Award at the Office for National St...
2018 Finalist - Innovators and Leaders - LaingBuisson Awards
21 November 2018
A finalist in the 'Rising Star' category of the LaingBuisson Health & Care Awards 2018. Under Professor Gordon Wish...
Home HPV tests as good as clinician collected cervical samples
21 November 2018
A recent US study published in Obstetrics & Gynecology has confirmed the prevalence of high-risk HPV types detected by se...
AXA PPP enhances prostate cancer diagnosis pathway
19 November 2018
AXA PPP healthcare has teamed up with screening service, Check4Cancer, to enhance its prostate cancer diagnosis pathway. ...
Evidence led services impress the judges at the Health Investor Awards
4 July 2018
It was third time lucky for Check4Cancer at the Health Investor Awards earlier this month.
Clinical excellence in One Stop pathway audit data presented at Association of Breast Surgery Conference
18 June 2018
Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, presents audit results from its private breast can...
Check4Cancer wins Diagnostics Provider of the Year at the 2018 Health Investor Awards
15 June 2018
Check4Cancer is delighted to announce it has been awarded ‘Diagnostics provider of the year’ at the 2018 Health...
Not quite the "Holy Grail" cancer blood test yet
1 June 2018
Professor Gordon Wishart, Chief Medical Officer at Check4Cancer comments on yesterday's front page Telegraph article ("Holy G...
Check4Cancer appoints Louise Mills as Clinical Services Director
23 May 2018
Check4Cancer is delighted to announce the appointment of Louise Mills as Director of Clinical Services.
Private providers expect surge in mammogram requests
9 May 2018
Private providers of screening mammograms such as BreastHealth UK (www.breasthealthuk.com) are expecting a surge in...
Third time lucky?!! Check4Cancer finalist in Health Investor Award for Diagnostics Provider of the Year
28 February 2018
By working closely with large corporate clients and UK private medical insurance companies, Check4Cancer has been able to mod...
'Gene-ius' Your DNA can tell you how likely you are to develop breast cancer
14 November 2017
Cambridge Magazine features Professor Gordon Wishart and the Check4Cancer team talking about MyBreastRisk, the first DNA sali...
Clinical governance in private hospitals
25 October 2017
‘How safe is your operation’ (BBC Panorama, 16.10.17) questions safety of surgical procedures in private sector.
Pr...
MyBreastRisk - new test launched!
10 October 2017
BreastHealth UK, part of the Check4Cancer group, launches MyBreastRisk - the first commercially available test that combines ...
Check4Cancer leads the way post Paterson
27 September 2017
The Paterson debacle will have damaged public confidence in private breast cancer diagnostics.
In response, Check4Canc...
Finalist in three categories at LaingBuisson healthcare awards for excellence 2017
13 September 2017
Check4Cancer is delighted to have been shortlisted as finalist in three separate categories of the Laing B...
Call for Whole Genome Sequencing to be offered to all cancer patients
19 July 2017
Professor Dame Sally Davies, Chief Medical Officer for England, calls for Whole Genome Sequencing to be offered to all...
Cancer in the workplace and what it means for HR
5 April 2017
A cancer diagnosis leads to a ripple effect across an entire organisation, presenting particular challenges in terms of ...
Check4Cancer & Cigna finalists for second year in ‘Best Diagnostics Provider’ category at Health Investor Awards
23 March 2017
Check4Cancer and Cigna have been working together for the past 14 months to tackle early detection of breast cancer and skin ...
Prof Gordon Wishart, Chief Medical Officer at Check4Cancer to feature on Cambridge TV discussing PREDICT algorithm for new ONCOassist app
3 October 2016
ONCOassist app adds PREDICT algorithm, licensed from Cambridge Enterprise, to help doctors make critical treatment decisions ...
